The curve shift method and the brain stimulation reward paradigm were
used to dissociate reward and performance changes and determine whethe
r unilateral ICV microinjection of neurotensin (3, 10, and 30 mu g/10
mu l) produces neuroleptic- or psychostimulant-like effect on a dopami
ne-dependent behavior. At the highest dose tested, neurotensin potenti
ated brain stimulation reward, producing a significant time-dependent
decrease in Frequency threshold. Neurotensin also suppressed maximal r
are of responding at every dose tested, suggesting that it was more ef
fective at attenuating performance capability. These results suggest t
hat a centrally acting neurotensin receptor agonist may specifically s
timulate dopamine-dependent behaviors. producing psychostimulant-like
effect that can be attenuated or masked by a suppression of performanc
e capability.